Cantel Medical Corp. (NYSE:CMN) CAO Steven C. Anaya sold 5,500 shares of the stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $77.07, for a total transaction of $423,885.00. Following the sale, the chief accounting officer now owns 48,132 shares in the company, valued at $3,709,533.24. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Cantel Medical Corp. (NYSE:CMN) traded up 0.30% on Wednesday, hitting $76.88. 118,110 shares of the company were exchanged. The firm has a 50 day moving average of $77.65 and a 200-day moving average of $71.18. Cantel Medical Corp. has a 52-week low of $53.64 and a 52-week high of $81.63. The stock has a market cap of $3.18 billion, a PE ratio of 53.46 and a beta of 1.59.

Cantel Medical Corp. (NYSE:CMN) last announced its quarterly earnings results on Thursday, September 29th. The company reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.11. The firm had revenue of $179 million for the quarter. Cantel Medical Corp. had a net margin of 9.02% and a return on equity of 16.70%. The company’s quarterly revenue was up 18.3% on a year-over-year basis. During the same period last year, the firm earned $0.39 earnings per share. On average, equities analysts expect that Cantel Medical Corp. will post $1.98 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Cantel Medical Corp. (NYSE:CMN)

A number of equities research analysts have commented on CMN shares. Benchmark Co. started coverage on shares of Cantel Medical Corp. in a research report on Monday, August 29th. They issued a “buy” rating and a $83.00 price objective on the stock. Needham & Company LLC started coverage on shares of Cantel Medical Corp. in a research report on Wednesday, August 24th. They issued a “hold” rating on the stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Aperio Group LLC boosted its position in shares of Cantel Medical Corp. by 26.4% in the first quarter. Aperio Group LLC now owns 10,167 shares of the company’s stock worth $726,000 after buying an additional 2,122 shares during the period. TIAA CREF Investment Management LLC boosted its position in shares of Cantel Medical Corp. by 10.6% in the first quarter. TIAA CREF Investment Management LLC now owns 156,155 shares of the company’s stock worth $11,143,000 after buying an additional 14,954 shares during the period. Prudential Financial Inc. boosted its position in shares of Cantel Medical Corp. by 3.4% in the first quarter. Prudential Financial Inc. now owns 171,696 shares of the company’s stock worth $12,253,000 after buying an additional 5,639 shares during the period. BlackRock Inc. boosted its position in shares of Cantel Medical Corp. by 119.5% in the first quarter. BlackRock Inc. now owns 2,355 shares of the company’s stock worth $168,000 after buying an additional 1,282 shares during the period. Finally, BlackRock Group LTD boosted its position in shares of Cantel Medical Corp. by 9.5% in the first quarter. BlackRock Group LTD now owns 42,830 shares of the company’s stock worth $3,056,000 after buying an additional 3,701 shares during the period. 81.60% of the stock is currently owned by hedge funds and other institutional investors.

About Cantel Medical Corp.

Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

5 Day Chart for NYSE:CMN

Receive News & Stock Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related stocks with our FREE daily email newsletter.